Jongheon Shin

Title: Jongheon Shin: Innovator in Histone Demethylase Inhibitors

Introduction

Jongheon Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors of histone demethylase. His innovative work has the potential to impact cancer treatment and other angiogenesis-related diseases.

Latest Patents

Jongheon Shin holds 2 patents that showcase his expertise in creating novel compounds. His latest patents include a compound, preparing method thereof, and use thereof as inhibitors of histone demethylase. This invention provides a new compound that effectively inhibits histone demethylase activity, which is crucial for regulating gene expression. Another notable patent is related to arteminolide derivatives and the process for their manufacture. These derivatives, obtained from Artemisia sylvatica, are effective farnesyl-protein transferase inhibitors and can suppress angiogenesis, making them valuable for treating various cancers.

Career Highlights

Throughout his career, Jongheon Shin has worked with esteemed organizations such as the Korea Institute of Science and Technology and Snur & Db Foundation. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Jongheon Shin has collaborated with notable colleagues, including Dong-Chan Oh and Seong-Hwan Kim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jongheon Shin is a distinguished inventor whose work in developing histone demethylase inhibitors is paving the way for advancements in cancer treatment. His contributions to the field are noteworthy and reflect his commitment to scientific innovation.